Cargando…
Consensus-based approach to managing opioids, including opioid misuse and opioid use disorder, in patients with serious illness: protocol for a modified Delphi process
INTRODUCTION: Management of opioid misuse and opioid use disorder (OUD) among individuals with serious illness is an important yet understudied issue. Palliative care clinicians caring for individuals with serious illness, many of whom may live for months or years, describe a complex tension between...
Autores principales: | King, Caroline, Arnold, Robert, Dao, Emily, Kapo, Jennifer, Liebschutz, Jane, Meier, Diane, Paice, Judith, Ritchie, Christine, Czajkowski, Kristen, Khodyakov, Dmitry, Merlin, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137210/ https://www.ncbi.nlm.nih.gov/pubmed/34011593 http://dx.doi.org/10.1136/bmjopen-2020-045402 |
Ejemplares similares
-
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015) -
Psychological barriers to the use of opioid analgesics for treating pain in patients with advanced recurrent cancer (BAROC): protocol for a multicentre cohort study
por: Tsuno, Takehiko, et al.
Publicado: (2022) -
Real-World Evidence for the Safety and Effectiveness of Naldemedine in the Management of Opioid-Induced Constipation in Patients With Cancer Pain: Post-hoc Subgroup Analysis of Post-marketing Surveillance in Japan
por: Naya, Noriyuki, et al.
Publicado: (2023) -
Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study
por: Matsuoka, Hiromichi, et al.
Publicado: (2017) -
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
por: Matsuoka, Hiromichi, et al.
Publicado: (2022)